| 4.81 0 (0%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.36 |
1-year : | 6.83 |
| Resists | First : | 5.44 |
Second : | 5.84 |
| Pivot price | 5.34 |
|||
| Supports | First : | 4.8 | Second : | 3.99 |
| MAs | MA(5) : | 5 |
MA(20) : | 5.31 |
| MA(100) : | 4.73  |
MA(250) : | 4.99 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 3.3 |
D(3) : | 11.3 |
| RSI | RSI(14): 38.3 | |||
| 52-week | High : | 10.28 | Low : | 3.93 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CELZ ] has closed above bottom band by 1.8%. Bollinger Bands are 28.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.88 - 4.91 | 4.91 - 4.93 |
| Low: | 4.74 - 4.77 | 4.77 - 4.81 |
| Close: | 4.76 - 4.81 | 4.81 - 4.86 |
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Fri, 29 Mar 2024
What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock - Yahoo Movies Canada
Wed, 27 Mar 2024
Creative Medical Technology Holdings Provides Corporate Update - Business Wire
Sun, 24 Mar 2024
Creative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Thu, 07 Mar 2024
Creative Medical Technology gains FDA nod for T1D therapy - Investing.com
Thu, 07 Mar 2024
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes ... - Yahoo Finance
Wed, 06 Mar 2024
Creative Medical Shares Rally Premarket on FDA Orphan Designation - MarketWatch
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 1.32e+006 (%) |
| Held by Institutions | 2.7 (%) |
| Shares Short | 13 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -5.53e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -59 % |
| Return on Assets (ttm) | 61.2 % |
| Return on Equity (ttm) | -23.5 % |
| Qtrly Rev. Growth | 9000 % |
| Gross Profit (p.s.) | -16.65 |
| Sales Per Share | -8.01 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -3.8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.61 |
| Price to Cash Flow | 3.21 |
| Dividend | 0 |
| Forward Dividend | 28710 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|